Impact of photobiomodulation therapy in patients with diagnosis of head and neck câncer under antineoplasic treatment
Impacto da terapia de fotobiomoduladora em pacientes com diagnóstico de câncer de cabeça e pescoço sob tratamento antineoplásico
Palavras-chave:
Photobiomodulation therapy, Treatment, Prevention, Oral mucositis, Head and neck cancerResumo
Assess the regimens of photobiomodulation therapy in clinical signal e symptoms of oral mucositis in patients with head and neck carcer during antineoplastic treatment. A retrospective search of medical records was carried out between the years 2016 to 2019 with patients diagnosed with head and neck cancer under prophylactic regimen with photobiomodulation therapy. Were collected demographic data, risk factors, oral condition, number of photobiomodulation therapy sessions, degree of mucositis, medical-hospital information. No statistically significant relationship was found between prophylactic photobiomodulation therapy and oral mucositis. But patients who used both prophylactic and therapeutic regimens were less chance to have severe lesions of oral mucositis. And the patients who underwent chemotherapy were more likely to have severe lesions. The absence of a statistically significant association between the prophylactic regimen of photobiomodulatation therapy contradicts the clinical evidence. But the overlap between the two regimens, therapeutic and prophylactic, treated severe mucositis and is in accordance with the literature. Future research to resolve this contradiction must be designed in a prospective models.
Downloads
Referências
ANTUNES, H.S. et al. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. RadiotherOncol. v.109, n.2, p.297–302, 2013.
ARANY, P. R. et al. Photoactivation of Endogenous Latent Transforming Growth Factor–β1 Directs Dental Stem Cell Differentiation for Regeneration. Sci Transl Med, v. 6, n. 238, 2014.
ARAÚJO, M. et al. Cancer patients with oral mucositis: challenges for nursing care. Revista Latino-Americana Enfermagem, v. 23, n. 2, p. 267–274, 2015.
BERTOLINI, M. et al. Chemotherapy induces oral mucositis in mice without additional noxious stimuli. Transl Oncol. v. 10, p. 612–620, 2017.
BJORDAL, J. M. et al. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Supportive Care in Cancer, v. 19, n. 8, p. 1069–1077, 2011.
BLAKAJ, A. et al. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncology, v. 95, n. April, p. 29–34, 2019.
CARNEIRO, V. S. M. et al. Effect of Low-Level Laser therapy on the fungal proliferation of Candida albicans. Mechanisms of Photobiomodulation Therapy XI. v.17, n.7, 9695-22, mar. 2016.
CARVALHO, P. A. G. et al. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: A double-blind randomized study in head and neck cancer patients. Oral Oncology, v. 47, n. 12, p. 1176–1181, 2011.
CHAN, C. W. H. et al. Oral mucositis among Chinese cancer patients receiving chemotherapy: Effects and management strategies. Asia-Pacific Journal of Clinical Oncology, v. 17, n. 2, p. e10–e17, 2021.
EILERS, J. et al. Evidence-based interventions for cancer treatment–related mucositis: Putting evidence into practice. Clinical Journal of Oncology Nursing, v. 18, n. 6, p. 80–96, 2015.
ELAD, S. et al. MASCC / ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy. Cancer, v. 1, n. 126, p. 4423–4431, 2020.
ELTING, L. S. et al. The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer, v. 98, n. 7, p. 1531–1539, 2003.
EPSTEIN, J. B.; BARASCH, A. Oral and Dental Health in Head and Neck Cancer Patients. Cancer Treatment and Research, v. 174, p. 43–57, 2018.
FEKRAZAD, R.; CHINIFORUSH, N. Oral Mucositis Prevention and Management by Therapeutic Laser in Head and Neck Cancers. Journal of Lasers in Medical Sciences, v. 5, n. 1, p. 1–7, 2014.
FERREIRA, M. H. et al. Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study. Supportive Care in Cancer, v. 28, n. 3, p. 1277–1287, 2020.
FREITAS, L. F. DE; HAMBLIN, M. R. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. Physiology & behavior, v. 22, n. 3, p. 1–18, 2016.
FROWEN, J.; HUGHES, R.; SKEAT, J. The prevalence of patient-reported dysphagia and oral complications in cancer patients. Support Care Cancer. v.28, n. 3, p.1141-1150, mar. 2020.
HONG, B.Y. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome.v.7, n. 66, p-18, abr. 2019.
INCA, M. DA S.-. Estimativa 2020 - Incidência de Câncer no Brasil.
LALLA, R. V. et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, v. 120, n. 10, p. 1453–1461, 2014.
LALLA, R. V et al. A systematic review of oral fungal infections in patients receiving cancer therapy Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Support Care Cancer., v. 18, n. 8, p. 985–992, 2010.
LOPES, F. et al. Effects of Low-Level Laser Therapy on Collagen Expression and Neutrophil Infiltrate in 5-Fluorouracil-Induced Oral Mucositis in Hamsters. Lasers in Surgery and Medicine, v. 42, n. Ago, p. 546–552, 2010.
MARÍN-CONDE, F. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial. Int J Oral Maxillofac Surg. v.48, n.7 p. 917-923, jul. 2019.
MARTINS, A. F. L. et al. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial. Trials. v.20, n. 97, fev. 2019.
MIGLIORATI, C. et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Supportive Care in Cancer, v. 21, p. 333–341, 2013.
MERCADANTE, S. et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. v.23, n.11, p. 3249-55, nov. 2015.
MORAIS M.O. et al. A prospective study on oral adverse effects in head and neck cancer patients submitted to a preventive oral care protocol. Support Care Cancer. v.28, n.9, p.4263-4273, set. 2020.
OBEROI, S. et al. Effect of Prophylactic Low Level Laser Therapy on Oral Mucositis: A Systematic Review and Meta-Analysis. PLoS One. v.9 (9), p. e107418, set. 2014.
PENG, J. et al. Low-level laser therapy in the prevention and treatment of oral mucositis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. v.130, n.4, p.387-397.e9, out. 2020.
PICO, J.; AVILA‐GARAVITO, A.; NACCACHE, P. Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. The Oncologist, v. 3, n. 6, p. 446–451, 1998.
REZK-ALLAH, S. S. et al. Effect of Low-Level Laser Therapy in Treatment of Chemotherapy Induced Oral Mucositis. J Lasers Med Sci. v.10, n. 2, p. 125-130, 2019.
SILVA, L. C. et al. The Impact of Low-Level Laser Therapy on Oral Mucositis and Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation Using the Oral Health Impact Profile and the Functional Assessment of Cancer Therapy-Bone Marrow Transplantation Que. Photomedicine and Laser Surgery, v. 33, n. 7, p. 357–363, 2015.
SILVEIRA, L. B. et al. Investigation of mast cells in human gingiva following low-intensity laser irradiation. Photomedicine and Laser Surgery, v. 26, n. 4, p. 315–321, 2008.
SOARES R.G. et al. Treatment of mucositis with combined 660- and 808-nm-wavelength low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study. Lasers Med Sci. v.33, n.8, p.1813-1819, nov. 2018.
SONIS, S. T. Oral mucositis. Anticancer Drugs, v. 22, p. 607–612, 2011.
SONIS, S. T. et al. Could the biological robustness of low-level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncology, v. 54, p. 7–14, 2016.
SOUZA, R.C. et al. Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans. Lasers Med Sci. v.25, n.3, p.385-389, maio 2010.
TOLENTINO, E. DE S. et al. Oral adverse effects of head and neck radiotherapy: Literature review and suggestion of a clinical oral care guideline for irradiated patients. Journal of Applied Oral Science, v. 19, n. 5, p. 448–454, 2011.
TROTTI, A. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiotherapy and Oncology, v. 66, n. 3, p. 253–262, 2003.
WONG, H.M. Oral complications and management strategies for patients undergoing cancer therapy. ScientificWorld Journal. n.8, jan. 2014.
ZADIK, Y. et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Supportive Care in Cancer, v. 27, n. 10, p. 3969–3983, 2019.
ZECHA, J. et al. Lowlevel laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Supportive Care in Cancer, v. 24, n. 6, p. 2781–2792, 2016.
